The WCC Note

Your Weekly Guide to Harmonizing Clinical Trial Imaging

Posts Tagged ‘molecular imaging’

2009: Looking Back and Looking Ahead in Imaging – Vol. 3, Number 11

Thursday, December 31st, 2009

Last summer while reviewing literature for this newsletter, I spent an afternoon on a porch elevated alongside an Idaho road.  While mountains made a diaphanous blanket of color in the distance, and breezes prickled through tree leaves that flickered and shuffled like molecules in entropy, it occurred to me that our understanding of disease processes, due to our ability to image them, has altered fundamentally since I entered radiology 20 years ago.  Rather like a J.D. Salinger’s Glass family member, I felt a kind of epiphany, as silly as that sounds, sitting in a lawn chair among the plants withering in the mountain heat.  And yet, it is this kind of realization about our profession – that it does not and will not stand still – that makes us so lucky to be a part of it.

As the panorama of molecular, in vivo cellular, and micro environmental imaging spreads before us, along with a continuing stream of new technologies that fire out of laboratories with so many endless possibilities, it is our great fortune to work in a profession that allows us, at its core, to serve as fly wheels of steady utility as diagnosticians and also play a role in medical innovations that are occurring today and that will continue to do so for years to come.

This year’s final issue of The WCC Note veers away from the mainstream of practiced radiology and takes us down less-traveled roads toward some experimental imaging highlights of 2009.  From Dr. Pomeranz and myself, we wish you very happy holidays and a joyous and healthy new year.

- Margaret D. Phillips and Stephen J. Pomeranz

ACCOLADES FOR IMAGING ADVANCES

In 2008, the Nobel Prize in Chemistry Went for the Discovery of Green Fluorescent Protein, Which Revolutionized the Imaging of Small Structures, Allowing In Vivo Cellular Imaging.  What Major Accolades Were Bestowed for Imaging This Year?

  1. Once again, a Nobel Prize went to imaging – this time for techniques that allow digital imaging and electronic communications, such as this newsletter.  These discoveries ultimately revolutionized the practice of radiology.
    a.  In 2009, the Nobel committee awarded the Physics prize for inventing an imaging semiconductor circuit, the charge-coupled device (CCD), and for developments in optical fibers that allowed communications based on transmission of light.
    b.  The prize went to two U.S. researchers, Willard S. Boyle and George E. Smith, from Bell Laboratories in Murray Hill, NJ, as well as Charles K. Kao of the United Kingdom and Hong Kong, China.
    c.  The charge-coupled device came to fruition from a desire to create a memory storage device, and it originated after a 1.5-hour discussion between Drs. Boyle and Smith one afternoon in 1969.  It relied on the photoelectric effect discovered by Einstein, for which Einstein himself won the Nobel Prize in 1921.  Attempting to make advances toward a picture phone, Boyle and Smith imagined arrays of photocells that would emit electrons in proportion to the intensity of incoming light.  The electrons in the photocells would then be read and thereby make an image – changing an optical image to a digital one.
    d.  In an online interview, Drs. Boyle and Smith were asked what set apart Bell Laboratories, which has received seven Nobel Prizes.  Their answers were freedom, intelligent management that allows pursuit of interests, an institution financially well positioned to afford appropriate equipment, and excellent people – allowing fellowship and interchange of ideas.
    e.  Dr. Kao used ultra-pure glass fibers to transmit light in 1966.  Since the frequency of light waves is so much greater than electrical waves, transmission is much faster than with copper cables and radio waves.
  2. The Japan Prize from the Science and Technology Foundation of Japan went to radiologist David Kuhl, M.D. from the University of Michigan.  His work in the 1950s developed radionuclide emission tomography that led to, among other areas, PET scanning.

NEW DIRECTIONS IN IMAGING

What Were Some Experimental or Progressive Techniques Published in 2009 That Reflect New Directions or Hold Promise for the Future?

  1. The in vivo tracking of cells with MRI has undergone clinical study outside the United States using superparamagnetic iron oxide particles.
  2. Imaging atoms within an organic molecule absorbed on a surface was performed with scanning tunneling microscopy.
  3. Breast-specific gamma imaging with a high-resolution gamma camera was reported to show 93 percent sensitivity in 28 biopsy-proved known lobular carcinomas, in a retrospective multicenter study.
  4. Molecular imaging of the breast underwent review with description of, among others, the gene array analysis of tumors, phenotypic imaged tumor differences, MR tumor spectroscopy, and fluorescent probe imaging.
  5. Atherosclerotic plaque was imaged in vivo at the molecular levels by using the MR contrast agent P947 that targets matrix metalloproteinases in plaque.
  6. Using infared imaging guidance, researchers caused subtotal ablation of mice tumors, which resulted in T-cell immune responses and tumor regression.
  7. Minimally invasive autopsy to detect cause of death as an alternative to conventional autopsy was reported to show 93 percent of overall findings and 94 percent of major findings.  The technique used whole-body CT, MR, and ultrasound-guided 12-gauge needle biopsy of the heart, both lungs, liver, both kidneys, and spleen.
  8. Apoptotic (early cell death) processes underwent time-lapse imaging in live cells.  Researchers used a polarity-sensitive biosensor with switchable fluorescence states that allowed only the apoptotic cells to be detected.
  9. Reporter gene imaging of human mesenchymal stem cells implanted in porcine myocardium was performed with PET-CT.
  10. A single atom could be imaged by detecting electrons emerging from its surface using an aberration-corrected electron microscope.

CONCLUSION

The year 2009 saw Nobel Prizes awarded for techniques that ultimately brought about digital imaging and filmless teleradiology, the Japan Prize given for radioisotope tomography leading to PET; and a myriad of experimental imaging science that increasingly refined and exploited visualization of small structures – down to the atomic level.

Research and reporting by Margaret D. Phillips, M.D.
Reviewer and publisher:  Stephen J. Pomeranz, M.D.

For full sources and credit, please download the PDF copy of the newsletter here

Micro-Imaging Advances
Vol. 3, Number 1

Wednesday, January 14th, 2009

SCANNING THE HORIZON

We at WorldCare Clinical send you best wishes for a happy new year!  In a departure from our regular format, this issue begins 2009 with a turn away from currently applied advances in medical imaging.  Like a telescope surveying the landscape of the future, however near or far off it may be, this issue profiles experimental and theoretical studies in which imaging is – or could be – of importance.
– Stephen J. Pomeranz, M.D., and Margaret D. Phillips, M.D., Contributing Editors

MICRO-IMAGING ADVANCES

From the Scientific Locomotive, Some Bullets Fired into the Future
The macroscopic features depicted on current radiological imaging studies reflect processes occurring at the cellular, and ultimately, the molecular and micro-environmental levels.  In this light, a number of more recent developments may ultimately influence the way we perceive and perform medical imaging – and may link some imaging techniques with disease interventions.

We begin the year by turning our lens toward the horizon.  The following studies, briefly profiled, serve as a sampling of the past year’s innovative literature.  They depict the depth and promise of newer scientific paths that may gain increasing currency in the years to come.

Molecular and Microscopic Imaging
The year 2008 saw the Nobel Prize in Chemistry awarded for the discovery of and research on a green fluorescent protein (GFP) in jellyfish, a finding which ultimately changed the scale on which imaging could be done.  This advance opened a door into the world of the minute – a path to structures of unprecedented small scale, affording cellular and molecular images of living organisms.

On a poignant note, Nobel Laureate Osamu Shimomura was 16 years old and working in a factory just 15 kilometers from Nagasaki, Japan on August 9, 1945.  As a high school student, he watched the U.S. B-29 bomber fly in overhead, and then survived the detonation of the atomic bomb.  Some recent studies based on fluorescent-tagged protein imaging include:

  • Combining optics and genetics to evaluate neural circuit dynamics, with models created of Parkinson’s disease, depression, and behavior relevant to autism
  • Imaging individual mRNA molecules
  • Observation of the dynamics in space and time of nearly 1,000 proteins in individual human cancer cells responding to the chemotherapy drug camptothecin
  • Observing the real-time assembly of individual virions in live cells, from initiation to budding and release
  • Imaging small pancreatic ductal carcinomas and precursor lesions by exploiting cell-surface cancer proteins

The ability to image cells and their microenvironment movedforward with studies such as these:

  • Imaging pH changes in cancer
  • Real-time imaging of cells accompanying cancer
  • Imaging the red-blood-cell membrane changes induced by malaria
  • Developing the MRI pulsing sequences that achieved rapid and accurate internal temperature images

The pursuit of molecular cancer imaging included these advances:

  • Creation of a dual-head dedicated gamma camera used with 99mTc sestamibi to detect breast lesions less than 1 centimeter
  • Development of a high-resolution positron emission mammography/tomography imaging and biopsy device to detect and diagnose breast cancer
  • Engineering of gold nanoparticles targeted to tumor selective antigens, allowing cancer detection at the molecular level using standard CT imaging

As we commence the 2009 edition of The WCC Note, it is our intention to continue keeping you informed of the newest and most seminal imaging-related literature.  Throughout the year, studies will be profiled that may directly or indirectly affect imaging’s role in healthcare.  We will examine new developments in imaging techniques, new hypotheses of disease process, and novel concepts of disease intervention – scientific advances which typically find their way to human use by first being tested in the clinical trial arena.